If Sen. Warren’s effort is successful, it would undermine a vital and extremely successful industry.
340B Drug Discount Program is a Nightmare
Like many other well-intended programs 340B has ended up both wasting money and failing to provide benefits for patients.
Kansas Bankrolls Buc-ee the Beaver
Kansas lawmakers gave tax-free public financing to a powerful private interest.
The Proposed Musk Efficiency Commission Could Save Trillions
Trump saying that trillions of dollars can be saved from a government efficiency commission headed by Musk isn’t an exaggeration.
Price Controls Are Always a Bad Idea
Prices controls have always disrupted the marketplace and created shortages or excesses.
The Future of the Universal Service Fund
To save taxpayer dollars, Congress should look at revamping the USF program instead of trying to expanding its contribution base.
The IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Not-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.
New Study Shows PBMs Lower Drug Prices
A new report challenges assertions made during the committee’s recent hearing on the role of pharmacy benefit managers.